MedPath

Extracorporeal membrane oxygenation in patients with coronavirus disease 2019

Completed
Conditions
PCR-proven COVID-19, resulting in respiratory or cardiorespiratory insufficiency, refractory to conventional therapies.
Registration Number
NL-OMON27273
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

Patients had to require ECMO during their hospital admission at the ICU.
- Patients had to be =18 years old.
- The ICU admission took place between March 1st 2020 up to December 31st
2020.

Exclusion Criteria

Patients without COVID-19 on ECMO

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To quantify patient and ECLS characteristics of patients on ECLS due to COVID-19.
Secondary Outcome Measures
NameTimeMethod
To quantify the incidence of complications, mortality and location of decease in patients on ECLS due to COVID-19.
© Copyright 2025. All Rights Reserved by MedPath